ALPS earnings date and last-quarter result: P/E -0.03. Updated 2026-07-23.
Alps Group (ALPS) Research Hub
Alps Group (ALPS) trades on NASDAQ, MY in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.3276 USD (-0.12%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.03, market cap 0.08B. This hub links to the full technical, earnings and options research available for ALPS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, MY |
| Last close | 0.3276 USD (-0.12%) |
| 52-week range | 0.2685 USD – 0.77 USD |
| Trend regime | Range |
| 14-day RSI | 23.9 (Oversold) |
| Trailing P/E | -0.03 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
Available research for ALPS
Covered Call on ALPS: how it works, illustrative setup around the real 0.3276 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ALPS: how it works, illustrative setup around the real 0.3276 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ALPS: how it works, illustrative setup around the real 0.3276 USD price, max profit/loss, breakeven and when to use it. Educational.
ALPS technical analysis: range, last 0.3276 USD, RSI 23.9, 52w range 0.2685 USD–0.77 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ALPS in?
Alps Group (ALPS) is classified under Healthcare (Biotechnology), listed on NASDAQ, MY.
Is ALPS in an uptrend or downtrend?
As of 2026-10-26, ALPS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ALPS's trailing P/E ratio?
ALPS's trailing P/E is -0.03, with a market cap of 0.08B. See the earnings research page for full valuation detail.